PROK
Income statement / Annual
Last year (2024), ProKidney Corp.'s total revenue was $76.00 K,
and the percentage change from the previous year is not available.
In 2024, ProKidney Corp.'s net income was -$61.19 M.
See ProKidney Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$76.00 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$76.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
1
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$127.67 M
|
$106.71 M
|
$82.07 M
|
$46.26 M
|
$21.04 M
|
$75.22 M
|
| General & Administrative Expenses |
$56.08 M
|
$44.82 M
|
$70.94 M
|
$8.86 M
|
$5.67 M
|
$4.16 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$314.00 K
|
$0.00
|
| Selling, General & Administrative Expenses |
$56.08 M
|
$44.82 M
|
$70.94 M
|
$8.86 M
|
$5.98 M
|
$4.16 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$183.75 M
|
$151.52 M
|
$153.01 M
|
$55.11 M
|
$27.02 M
|
$79.38 M
|
| Cost And Expenses |
$183.75 M
|
$151.52 M
|
$153.01 M
|
$55.11 M
|
$27.02 M
|
$79.38 M
|
| Interest Income |
$19.75 M
|
$22.08 M
|
$5.98 M
|
$2.00 K
|
$43.00 K
|
$126.00
|
| Interest Expense |
$9.00 K
|
$12.00 K
|
$215.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$5.43 M
|
$3.85 M
|
$3.04 M
|
$1.98 M
|
$964.00 K
|
$867.00 K
|
| EBITDA |
-$158.49 M |
-$125.59 M |
-$143.99 M |
-$53.12 M |
-$26.06 M |
-$18.29 M |
| EBITDA Ratio |
-2085.42
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-2416.79
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$19.74 M
|
$22.07 M
|
$5.77 M
|
$2.00 K
|
$43.00 K
|
$126.00 K
|
| Income Before Tax |
-$163.93 M
|
-$129.45 M
|
-$147.24 M
|
-$55.11 M
|
-$26.98 M
|
-$79.25 M
|
| Income Before Tax Ratio |
-2157.01
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$598.00 K
|
$6.00 M
|
$896.00 K
|
$38.00 K
|
-$232.00 K
|
$361.00 K
|
| Net Income |
-$61.19 M
|
-$35.47 M
|
-$108.03 M
|
-$55.15 M
|
-$26.75 M
|
-$79.62 M
|
| Net Income Ratio |
-805.08
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.62 |
-0.57 |
-1.76 |
-1.73 |
-0.14 |
-1.01 |
| EPS Diluted |
-0.62 |
-0.57 |
-1.76 |
-1.73 |
-0.14 |
-1.01 |
| Weighted Average Shares Out |
$97.92 M
|
$61.71 M
|
$61.54 M
|
$31.89 M
|
$186.50 M
|
$78.53 M
|
| Weighted Average Shares Out Diluted |
$97.92 M
|
$61.71 M
|
$61.54 M
|
$31.89 M
|
$186.50 M
|
$78.53 M
|
| Link |
|
|
|
|
|
|
